CO6870004A2 - Métodos de modulación de un microarn en el tratamiento de la hipertensión arterial pulmonar - Google Patents

Métodos de modulación de un microarn en el tratamiento de la hipertensión arterial pulmonar

Info

Publication number
CO6870004A2
CO6870004A2 CO13268130A CO13268130A CO6870004A2 CO 6870004 A2 CO6870004 A2 CO 6870004A2 CO 13268130 A CO13268130 A CO 13268130A CO 13268130 A CO13268130 A CO 13268130A CO 6870004 A2 CO6870004 A2 CO 6870004A2
Authority
CO
Colombia
Prior art keywords
microarn
modulating
treatment
methods
arterial hypertension
Prior art date
Application number
CO13268130A
Other languages
English (en)
Spanish (es)
Inventor
Andrew Baker
Margaret Maclean
Nicholas Morrell
Original Assignee
Univ Court Of The University Os Glasgow
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Court Of The University Os Glasgow, Cambridge Entpr Ltd filed Critical Univ Court Of The University Os Glasgow
Publication of CO6870004A2 publication Critical patent/CO6870004A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure
    • C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CO13268130A 2011-05-09 2013-11-14 Métodos de modulación de un microarn en el tratamiento de la hipertensión arterial pulmonar CO6870004A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161484091P 2011-05-09 2011-05-09
US201261605376P 2012-03-01 2012-03-01

Publications (1)

Publication Number Publication Date
CO6870004A2 true CO6870004A2 (es) 2014-02-20

Family

ID=46178572

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13268130A CO6870004A2 (es) 2011-05-09 2013-11-14 Métodos de modulación de un microarn en el tratamiento de la hipertensión arterial pulmonar

Country Status (11)

Country Link
US (1) US9267134B2 (enExample)
EP (1) EP2707485B1 (enExample)
JP (1) JP6049700B2 (enExample)
KR (1) KR20140037868A (enExample)
CN (1) CN103814131A (enExample)
AU (1) AU2012252165A1 (enExample)
BR (1) BR112013029016A2 (enExample)
CA (1) CA2835568A1 (enExample)
CO (1) CO6870004A2 (enExample)
SG (1) SG194901A1 (enExample)
WO (1) WO2012153135A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970968B1 (en) 2013-03-15 2018-01-10 Miragen Therapeutics, Inc. Bridged bicyclic nucleosides
US9752143B2 (en) 2013-03-15 2017-09-05 MiRagen Therapeutics, Inc. Locked nucleic acid inhibitor of miR-145 and uses thereof
WO2015082896A1 (en) * 2013-12-02 2015-06-11 The University Court Of The University Of Glasgow Materials and methods for treatment of pulmonary arterial hypertension
CA2956256A1 (en) * 2014-08-01 2016-02-04 The Brigham And Women's Hospital, Inc. Methods and compositions relating to treatment of pulmonary arterial hypertension
BR112017014914B1 (pt) * 2015-01-13 2023-11-14 Vivus, Inc Uso de uma combinação de tacrolimus e um segundo agente ativo eficaz no tratamento ou prevenção da hipertensão pulmonar
CN110088278B (zh) * 2016-10-31 2023-08-11 e-NA生物科技公司 双链核酸分子及其用途
CN115175685B (zh) * 2019-12-09 2024-12-13 艾姆皮瑞克公司 用于治疗血管生成素样4(angptl4)相关疾病的寡核苷酸
JP2024504679A (ja) * 2021-01-18 2024-02-01 リジェン イノファーム インコーポレイテッド ｍｉＲ１４５阻害剤を有効成分として含む心筋梗塞の治療用組成物
CN113332306A (zh) * 2021-04-28 2021-09-03 武汉华纪元生物技术开发有限公司 用于治疗肺动脉高血压的microRNA-30a抑制剂及其应用
GB202215974D0 (en) * 2022-10-28 2022-12-14 Imperial College Innovations Ltd Microrna panels for pulmonary hypertension

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060451A (en) 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
WO1995003843A1 (en) 1993-07-30 1995-02-09 The Regents Of The University Of California Endocardial infusion catheter
GB9525620D0 (en) 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
SE9600216D0 (sv) 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
ATE211741T1 (de) 1996-05-31 2002-01-15 C & C Res Lab Aromatische amidinderivate als selektive thrombininhibitoren
US5985833A (en) 1996-09-17 1999-11-16 Wisconsin Alumni Research Foundation Thrombin inhibitor
US6416510B1 (en) 1997-03-13 2002-07-09 Biocardia, Inc. Drug delivery catheters that attach to tissue and methods for their use
US6147109A (en) 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
SI20474A (sl) 1998-05-26 2001-08-31 Icn Pharmaceuticals, Inc. Novi nukleozidi, ki imajo bicikličen sladkorni del
EP1117398A2 (en) 1998-09-28 2001-07-25 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
US6838283B2 (en) 1998-09-29 2005-01-04 Isis Pharmaceuticals Inc. Antisense modulation of survivin expression
US6693187B1 (en) 2000-10-17 2004-02-17 Lievre Cornu Llc Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge
EP1648914A4 (en) * 2003-07-31 2009-12-16 Regulus Therapeutics Inc OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
US20070203445A1 (en) 2004-02-26 2007-08-30 V-Kardia Pty Ltd Isolating cardiac circulation
BRPI0508073A (pt) 2004-02-26 2007-07-17 Kardia Pty Ltd V método e aparelho para isolar substancialmente circulação cardìaca da circulação sistêmica aparelho para perfundir o coração com um agente terapêutico, cateter de obstrução para obstruir fluxo entre um vaso principal e um ou mais vasos ramificados, método para administrar um agente terapêutico ao coração e estrutura de suporte percutaneamente administrável para manter patência do sinus coronário
US7722596B2 (en) 2004-02-26 2010-05-25 Osprey Medical, Inc. Regional cardiac tissue treatment
WO2006089340A2 (en) 2005-02-23 2006-08-31 V-Kardia Pty Ltd Polynucleotide delivery to cardiac tissue
CN101448942B (zh) 2005-12-12 2014-04-23 北卡罗来纳大学查珀尔希尔分校 调节肌细胞增殖和分化的microrna
WO2009121031A1 (en) 2008-03-27 2009-10-01 Vascular Biosciences, Inc. Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases
US8735568B2 (en) 2009-03-09 2014-05-27 The J. David Gladstone Institutes Methods of modulating smooth muscle cell proliferation and differentiation
CN101843632B (zh) * 2009-03-24 2012-07-04 复旦大学附属华山医院 miR-145在制备治疗炎症药物中的应用
SG176716A1 (en) * 2009-06-08 2012-01-30 Miragen Therapeutics CHEMICAL MODIFICATION MOTIFS FOR miRNA INHIBITORS AND MIMETICS
US20130005658A1 (en) * 2009-12-15 2013-01-03 Board Of Regents, The University Of Texas System Micro-rna regulation in ischemia and ischemia-reperfusion injury
CN102382824A (zh) * 2010-09-01 2012-03-21 中国科学院上海药物研究所 人miR-145反义核酸及其应用

Also Published As

Publication number Publication date
BR112013029016A2 (pt) 2017-01-17
EP2707485A1 (en) 2014-03-19
KR20140037868A (ko) 2014-03-27
WO2012153135A1 (en) 2012-11-15
SG194901A1 (en) 2013-12-30
JP6049700B2 (ja) 2016-12-21
US9267134B2 (en) 2016-02-23
JP2014516027A (ja) 2014-07-07
CA2835568A1 (en) 2012-11-15
CN103814131A (zh) 2014-05-21
EP2707485B1 (en) 2016-12-14
US20140163086A1 (en) 2014-06-12
AU2012252165A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
CO6870004A2 (es) Métodos de modulación de un microarn en el tratamiento de la hipertensión arterial pulmonar
DK3646824T3 (da) Kateterbaseret hjerteklapprotese
EP2692370A4 (en) ARTIFICIAL LUNG
BR112013019556A2 (pt) válvula cardíaca protética
BR112013033332A2 (pt) calçado
IL231228A0 (en) Bicyclic heterocycle derivatives for the treatmen t of pulmonary arterial hypertension
EP3598914C0 (en) SHOE
EP2748014A4 (en) TIRE TREAD TIRE
EP2661169A4 (en) SELF-DRIVEN FUSIONING
EP2599430A4 (en) Borescope
FR2972906B1 (fr) Chaussure a amorti et propulsion ameliores
DK3011936T3 (da) Vævsmanipulerede konstrukter
EP2725663A4 (en) CONNECTOR
EP2774585A4 (en) Stent
EP2770969A4 (en) Bed chair
DE112011105163T8 (de) Wirbelströmungserzeuger
EP2780012A4 (en) Methods of treatment with deferiprone
FI20115336A0 (fi) Suihkutuspää
BR112013033512A2 (pt) poliamida ramificada
LT2704711T (lt) Fk506 panaudojimas plaučių arterinei hipertenzijai gydyti
EP2691653A4 (en) COMPRESSOR
EP2735741A4 (en) COMPRESSOR
IL228729A0 (en) Treatment regimens
FR2980341B1 (fr) Parasol gonflable
ES1075247Y (es) Cortina parasol multiposicional

Legal Events

Date Code Title Description
FA Application withdrawn